The Traditional Chinese Medicine syndromes of psoriasis in Chinese patients: Contribution of demographic and clinical variables

This article was to examine the specific contribution of demographic, medical and psychological variables to the Traditional Chinese Medicine (TCM) Syndromes of psoriasis. A cross-sectional survey of psoriasis patients was conducted at 7 hospitals of TCM of different regions. In all, 671 psoriasis patients underwent a clinical assessment including differentiation of TCM syndromes and psoriasis severity (assessed by Psoriasis Area and Severity Index, PASI). Patients also completed questions on demographic data and a quality of life scale (Dermatology Life Quality Index, DLQI). The three main TCM syndromes were included: 354 patients with Wind-heat (52.8%), 161 with Blood-stasis (24.0%), and 156 with Blood-dryness (23.2%). They distributed differently in subgroups of patients with different gender, age, chronic disease, duration of psoriasis, PASI, and DLQI score. The TCM syndromes were close related to demographic and clinical conditions of patients. TCM clinical treatment should consider both characteristics of syndrome and demographic variables of psoriasis.

[1]  Wang Ju-sheng Study on the Distribution and Development Rules of TCM Syndromes of 2651 Psoriasis Vulgaris Cases , 2008 .

[2]  W. Xiaoyan,et al.  Prevalence of Psoriasis in China:An Epidemiological Survey in Six Provinces , 2010 .

[3]  J. Koo,et al.  Traditional Chinese medicine for the treatment of dermatologic disorders. , 1998, Archives of dermatology.

[4]  C. Griffiths,et al.  Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. , 2008, Clinics in dermatology.

[5]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[6]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[7]  Shu-Chen Chang,et al.  Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. , 2008, Archives of dermatology.

[8]  B. Thiers Pathogenesis and clinical features of psoriasis , 2008 .

[9]  J. Billings,et al.  Cyclosporine improves psoriasis in a double-blind study. , 1986, JAMA.

[10]  T Fredriksson,et al.  Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.

[11]  A. Finlay,et al.  The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results , 2008, The British journal of dermatology.

[12]  C. Griffiths,et al.  Psoriasis: epidemiology, clinical features, and quality of life , 2005, Annals of the rheumatic diseases.

[13]  Qu Xing,et al.  Study on the Rule of Distribution of TCM Syndromes of Psoriasis , 1993 .

[14]  D. Ford,et al.  Role of Depression in Quality of Life for Patients with Psoriasis , 2007, Dermatology.